🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Diarrhea

Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections NCT03895593n/a1 site📍 Nanjing The Second Hospital of Nanjing Medical University · Tests: rescue fecal microbiota transplantation Treatment of Moderate to Severe Refractory Crohn's Disease NCT06721962Phase 1, Phase 213 sites📍 Scottsdale📍 Sacramento📍 San Francisco Tr1X, Inc. · Tests: TRX103, Cyclophosphamide Management of Shock in Children With SAM or Severe Underweight and Diarrhea NCT04750070Phase 31 site📍 Dhaka International Centre for Diarrhoeal Disease Research, Bangl… · Tests: Blood and Dopamine, Blood and adrenaline Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome NCT06737666Phase 11 site📍 Beijing Xiyuan Hospital of China Academy of Chinese Medical Sciences · Tests: Tong-Xie-Yao-Fang A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants NCT07716410n/a4 sites📍 Kisumu📍 Kuantan📍 Kuala Lumpur Novartis Pharmaceuticals Impact Evaluation of Accelerating Climate-Resilient Water, Sanitation and Hygiene Services for Schools and Healthcare Facilities in Karamoja NCT07823231NA1 site📍 Moroto Elijah Kipchumba · Tests: Climate-resilient school WASH infrastructure package, WASH and menstrual health capacity building and social and behavi… Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete NCT07444008NA1 site📍 Saint Petersburg NovoNatum Ltd · Tests: BioAmicus Complete, Placebo Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea NCT07285785Phase 410 sites📍 Lynwood📍 Hialeah📍 Miami Bausch Health Americas, Inc. · Tests: Rifaximin 200 mg Tablet, Oral Rehydration Therapy (ORT) Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea NCT07264998n/a1 site📍 Wuhan Hubei Cancer Hospital Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome NCT06681012NA12 sites📍 Leuven📍 Bobigny📍 Rouen Devintec Sagl · Tests: Gelsectan®, Placebo Magnesium in Gastrointestinal Disease NCT07338565n/a1 site📍 Aarhus N University of Aarhus Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI) NCT06003816NA2 sites📍 Dhaka📍 Dhaka Johns Hopkins Bloomberg School of Public Health · Tests: Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) CATI, Standard message Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery NCT05296681Phase 210 sites📍 Hamilton📍 Lakewood📍 Lakewood Howard S. Hochster, MD · Tests: NBT-NM108 Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) NCT05663775Phase 21 site📍 Edmonton AHS Cancer Control Alberta · Tests: Mesalamine Phenotype and Multi-omics Analysis of Children With Congenital Diarrhea and Enteropathy in China NCT06356545n/a1 site📍 Shanghai Children's Hospital of Fudan University Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial NCT07581756NA1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: rTMS group, sham device Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, or Stress NCT07656623NA1 site📍 Hanoi Institute of Gastroenterology and Hepatology, Vietnam · Tests: Ecologic Barrier, Ecologic Barrier Natural History of Clostridioides Difficile Infection NCT04801862n/a15 sites📍 Alicante📍 Orihuela📍 Villajoyosa Hospital Universitario de Valme Efficacy of Rifaximin With NAC in IBS-D NCT06727422Phase 21 site📍 Los Angeles Mark Pimentel, MD · Tests: rifaximin 66mg + N-acetylcysteine 560mg three times daily, RNIB21 containing rifaximin 132mg + N-acetylcysteine 560mg t… Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid Malabsorption and Small Intestinal Bacterial Overgrowth Using a Novel Sampling Device NCT06927011n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Capscan Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy NCT06576986NA1 site📍 Belo Horizonte Federal University of Minas Gerais · Tests: Symbiotic, Maltodextrin Hens Hatching Hope NCT04721197NA1 site📍 Concepción Georgia Southern University · Tests: Egg vouchers, Standard of Care Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants. NCT06031025n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Questionnaire, clinical examination FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis NCT06206707NA1 site📍 Aarhus N University of Aarhus · Tests: Faecal Microbiota Transplantation (FMT), Placebo ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea NCT07767370EARLY Phase 11 site📍 Nanjing The Second Hospital of Nanjing Medical University · Tests: mesalazine, ND-12, ND-12/H-6 A Study of SER-155 to Treat Diarrhea in People on Immunotherapy NCT06801067Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: SER-155 Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients NCT04038619Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Fecal Microbiota Transplantation, Loperamide Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults NCT06907498NA1 site📍 Ramat Gan Sheba Medical Center · Tests: Paromomycin A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) NCT07519395Phase 2114 sites📍 Anniston📍 Guntersville📍 Mobile GlaxoSmithKline · Tests: Placebo, Camlipixant Lf-rTMS Attenuates Visceral Pain in Irritable Bowel Syndrome With Diarrhea NCT06757491NA1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Repetitive Transcranial Magnetic Stimulation, Sham (No Treatment)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy